Abstract
Thirty-four isolates of pan-resistant Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase (MBL) were detected at a university hospital in Spain (July 2004-September 2006). Eleven (32%) patients had clinically significant infections, and three (27%) of these patients died. A single clone of MBL-producing P. aeruginosa was identified by pulsed-field gel electrophoresis. A cluster of isolates associated with the vascular surgery ward involved ten patients and appeared as a series of low-grade, sustained and misdiagnosed endemic infections in the hospital. The identification of MBL-positive P. aeruginosa should be considered mandatory in the surveillance of pan-resistant P. aeruginosa and requires a high index of suspicion in the context of endemic infections with a low attack rate.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Anti-Bacterial Agents / pharmacology
-
Cross Infection / epidemiology
-
Cross Infection / microbiology
-
Cross Infection / transmission*
-
Drug Resistance, Multiple, Bacterial*
-
Electrophoresis, Gel, Pulsed-Field
-
Endemic Diseases
-
Female
-
Hospitals, University
-
Humans
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
-
Population Surveillance*
-
Pseudomonas Infections / epidemiology
-
Pseudomonas Infections / microbiology
-
Pseudomonas Infections / transmission*
-
Pseudomonas aeruginosa / drug effects
-
Pseudomonas aeruginosa / enzymology*
-
Pseudomonas aeruginosa / genetics
-
Pseudomonas aeruginosa / pathogenicity
-
Spain / epidemiology
-
beta-Lactamases / biosynthesis*
-
beta-Lactamases / genetics
Substances
-
Anti-Bacterial Agents
-
beta-lactamase bla(vim-2)
-
beta-Lactamases